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Chemical Liver Carcinogenesis:
Monitoring of the Process by Flow
Cytometric DNA Measurements
by Vemund Digernes*
The carcinogenic process in the liver was monitored from early nonneoplastic changes to the de-
velopment of tumors in two well-known models; IP administration of dimethylnitrosamine (DMN) to
newborn mice, and feeding of rats with acetylaminofluorene (AAF). Liver parenchyma cells and
liver tumor cells were isolated by collagenase treatment and prepared for flow cytometric (FCM)
measurements of nuclear DNA content. The changes observed were correlated to morphology and
3H-thymidine incorporation.
The early preneoplastic changes in hepatocytes from DMN-treated mice were shifts in the DNA
content to classes of higher nuclear ploidies. AAF-feeding of rats caused gradual distortion of the
DNA content of nuclei from parenchymal cells. After 16 weeks of exposure, before any tumors were
seen, a majority of the nuclei displayed an aneuploid DNA content.
The significance of these changes in the carcinogenic process is discussed, and a possible use of
these models for detection of hepatotropic agents and agents causing aneuploidy (clastogens and
turbagens) is proposed. The liver neoplasias (adenomas and hepatocellular carcinomas) induced by
these models contained tumor stemlines with diploid DNA content, and some hepatocellular carcino-
mas showed aneuploidy. Nodules of hyperplasia contained diploid and tetraploid stemline.
Introduction
Flow cytometry has improved our ability to mea-
sure constituents of individual cells in a rapid and
exact manner. Applied as a cell kinetic method, it
quantitates the relative distribution of cells with G1-
S and G2 phase DNA content (Fig. 1). In addition,
flow cytometric DNA measurements can detect con-
ditions like polyploidy, aneuploidy and clonal
growth. These are biological phenomena which ear-
lier methods like chromosome counting and micro-
spectrofluorometry have shown to be associated
with some aspects of carcinogenesis and tumor
biology.
Polyploidy implies the multiple of chromosome
number and DNA content of nuclei and is thought
to accompany adaptation to extreme growth condi-
tions. Polyploidy is linked to carcinogenesis, both as
a finding in early stages of carcinogenesis and as an
effect of carcinogens in several systems. The fre-
quent occurrence of tetraploid or near tetraploid tu-
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mor stemlines also indicates that a polyploidization
may take place at some stage in tumor develop-
ment.
Aneuploidy may be caused by clastogens and tur-
bagens. Clastogens are substances that cause
chromosomal breaks, and turbagens interfere with
the spindle apparatus. This can cause loss of DNA
material or unequal distribution of DNA to
daughter cells during mitosis. Agents causing aneu-
plody are strongly suspected to be carcinogens or
teratogens, which can be detected by the micronu-
cleus test, sister chromatid exchange and other cy-
togenetic methods as well as flow cytometry.
Clonal growth is a characteristic feature of tu-
mors, and aneuploid DNA content of tumor stem-
lines is recognized as a marker of malignant growth,
however euploid stemlines are also found both in
malignant and benign tumors.
The occurrence of polyploidy, aneuploidy and
clonal growth in liver carcinogenesis can be moni-
tored by FCM as shown in the experiments summa-
rized here. The role of these phenomena in the path-
ogenesis of liver tumors, and a possible use of these
experimental models for testing of suspected carcin-
ogens and cocarcinogens are discussed.V. DIGERNES
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FIGURE 1. Relative distribution within the cell cycle phases
(above) of hepatocytes from newborn mouse expressed
according to DNA content in the FCM histogram (below).
The diploid G1 channel corresponds to DNA fluorescence
of standard spleen lymphocytes.
Material and Methods
Animal Models
The models used were the exposure of newborn
mice to dimethylnitrosamine (DMN), and low-dose
feeding of rats with acetylaminofluorene (AAF). In
both series, the changes occurring during the treat-
ment and the resulting liver tumors were investi-
gated by flow cytometric measurements (FCM).
FCM shows that mature hepatocytes have the
following distribution in the mouse liver: a few dip-
loid cells, mostly tetraploid and octoploid cells and a
few 16-ploid cells (Fig. 2) (1).
Rat hepatocytes comprise diploid, tetraploid and
a few octoploid cells (Fig. 3). These differences in
the distribution of hepatocytes in mice compared to
rats, make it easier to detect shifts among the
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FIGURE 2. (Top) Polyploidization as cell cycles without
mitotic division, thereby forming classes of higher ploidies.
The histograms (bottom) show the DNA content of hepato-
cytes from growing mouse liver distributed in a diploid, a
tetraploid and a small octoploid population, with S-phase
pulses in between, and the ploidy classes of the mature
mouse liver.
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FIGURE 3. A proposed mechanism for the formation of
aneuploid hepatocytes is shown (top). If substances in-
terfere with the spindle apparatus causing nondisjunction
or induce chromosome breaks with subsequent unequal
mitotic distribution of genetic material or loss of genetic
material, this will lead to gradually increasing populations
with aneuploid DNA content. The speed of this process
depends on mitotic activity and survival of altered cells.
The histograms of normal rat hepatocytes (left) and
hepatocytes from a rat exposed to AAF for 4 months
(right) are shown (Digernes et al. manuscript in
preparation). The shaded areas represent aneuploid DNA
values.
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ploidy classes in mice, especially because the admix-
ture of nonparenchymal cells interferes very little
with the results.
The normal process of polyploidization in mouse
liver and its modulation by DMN given during a
limited period was measured by FCM (2). The treat-
ment schedule as described by Vesselinovich (3) con-
sisted of 6 IP injections of a 0.4% solution of DMN
in 0.9% saline (2 ,g/g body weight) at 3-day inter-
vals from the age of 6 days to the age of 21 days. A
total of 54 mice (NMRI) of both sexes were exposed
to this treatment, while 52 untreated mice served
as controls. From each group, four animals (two of
each sex) were killed at weekly intervals until the
age of 52 days, when a stable ploidy pattern was
reached.
Thirty treated animals and 24 control animals
were kept until the age of 8 to 11 months, when
most of the male mice and some of the female mice
had developed liver tumors. These tumors were the
source of the investigation on the ploidy of tumor
stemlines, which were correlated with the morpho-
logical classification of the tumors as hyperplastic
nodules, adenomas and hepatocellular carcinomas
(4).
The rats were given low doses of AAF to try to
avoid acute cell toxicity. Twenty-five male Wistar
rats (180 g body weight) were given 0.025% AAF in
a low-protein diet. From week 5 to the week 16 the
animals were killed off at approximately weekly in-
tervals. Samples of liver tissue were prepared for
histology, and suspensions of viable hepatocytes
were isolated by collagenase perfusion and centrifu-
gation. The proliferative activity of these hepato-
cytes could then be examined by measuring thymi-
dine incorporation in short-term cultures, and the
DNA content of individual cells was measured by
FCM (5).
This in vivo/in vitro approach has also been used
for investigation of the proliferative response after
hepatectomy, where a good correlation between
amount of S-phase cells detected by FCM and thy-
midine labeling was found (5).
After the AAF treatment, we gave one group of
rats 0.05% phenobarbital in their drinking water in
order to promote the appearance of liver tumors.
The animals were killed after 12-18 months. The tu-
mors were examined histologically, and the tumor
cells were analyzed by FCM.
Isolation of Hepatocytes and Tumor Cells
Mouse liver cells were isolated by short in situ
perfusion through the portal vein with Ca-free colla-
genase solution, followed by incubation of liver tis-
sue slices in the collagenase solution with Ca added
after 30 min. After 25 min the slices were dispersed
into a single cell suspension. The proportion of par-
enchymal cells was enriched to about 90% by two
subsequent low-speed centrifugations.
Viable rat hepatocytes from the AAF-exposed
rats were obtained by in vitro collagenase perfusion
and low-speed centrifugation (6). Samples of this cell
suspension were taken for FCM, and for in vitro in-
corporation of 3H-thymidine in short-term cultures.
Visible liver tumors were isolated. One half of
each tumor was dissected free from the sur-
rounding liver tissue, sliced and dispersed into a
single cell suspension by incubation in collagenase
solution. The other half with surrounding liver tis-
sue was fixed in formalin and processed for histolog-
ical examination.
Preparation and Staining of Cells and Flow
Cytometric DNA Measurements
Nuclei were prepared by cell lysis in distilled
water and incubation with RNase (lmg/mL, 370C,
60 min), followed by treatment with detergent
(0.2%, 200C, 30 min) and pepsin (0.4%, 370C, 15
min). The nuclei were then stained with ethidium
bromide (10Mg/mL in 0.1 M Tris buffer pH 7.5). Opti-
mal staining was obtained after 15 min at 200C.
Some samples were stained with mithramycin (25
,ug/mL in 20% ethanol, 5 mM MgCl2). The nuclei
were prepared as described above but the RNase
treatment was omitted. Optimal staining was ob-
tained after 20 hr at 200C.
The distribution of DNA fluorescence of the nu-
clei was determined by using an ICP 11 pulse cyto-
meter. Each histogram represents measurement of
about 5-10 x 103 nuclei. The preparation method
described is shown to separate nuclei from binucle-
ated hepatocytes only to a small extent (1). Such
"pairs of nuclei" give only one pulse and are thus
measured as a single nucleus. The ploidy classes of
hepatocytes as quantitated by this FCM method
therefore correspond largely to cellular ploidy.
Results and Discussion
Polyploidization ofMouse Hepatocytes
and Effects of Dimethyl Nitrosamine
Maturation of the mouse liver was characterized
by the development of polyploidy. During the first 6
weeks after birth the cell population changed from
a purely diploid one to a combination of diploid, te-
traploid, octoploid and 16-ploid cells (Fig. 2), and this
distribution was normally maintained during the
whole life span of the animal. The administration of
DMN to newborn mice during the period when the
polyploidization starts enhanced this process, and
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the resulting shift to higher ploidies also involved
the occurrence of 32-ploid nuclei. This state of in-
creased polyploidy seemed to be maintained
throughout adult life and was seen in both male
mice, which are strongly susceptible to the hepato-
carcinogenic effect of DMN, and in the less suscep-
tible female mice. The increase in ploidy implied an
increase in cellular ploidy, because the nuclei in bi-
nucleated cells were only separated to a very small
extent by the preparation method used here.
Christie et al. (7) recognized a shift to higher ploi-
dies in rat liver following DMN treatment. In their
extensive study using Feulgen technique for DNA
measurements and morphometry of the nuclei they
also found a close relation between size and ploidy
and advanced the hypothesis that the appearance of
macronuclei may be the sign of a general shift to
higher ploidies. The macronuclei phenomenon seen
in mouse or rat liver in animals treated with vari-
ous carcinogens like nitrofen (8), o-aminoazotoluene
(9), pyrrolizidine alkaloids (10), aflatoxin (11), methyl-
azoxymethanol acetate (12),N-nitrosomorpholine (13)
or cadmium (14) may thus indicate that many of the
hepatocytes are affected. Shifts to higher ploidy
classes in liver of rodents exposed to carbon tetra-
chloride (15), N-nitrosomorpholine (16), and barbitu-
rate (17) have been found by DNA measurements of
individual cells. DMN, barbiturate, carbon tetra-
chloride and N-nitrosomorpholine gave increases in
both nuclear and cellular ploidy. In a study exposing
rats to lindane, Schulte-Hermann (18) found a reduc-
tion in binuclearity concomitantly with an increase
in nuclear size, indicating an unchanged cellular
ploidy.
The reversibility of the ploidy changes is another
aspect which has not been clarified. The increase in
ploidy following barbiturate treatment (17) is re-
versible, whereas DMN-induced changes can be
seen months after a single treatment (own unpub-
lished observations), and the macronuclei described
in the literature are also often found after discontin-
uation of the treatment. Liver cell dysplasia, de-
fined as cellular enlargement, nuclear pleomorphism
and multinucleation, has been identified as a prema-
lignant condition in humans (19).
Polyploidization is seen in other organ systems as
an effect of carcinogens or suspected carcinogens;
e.g., myleran induces polyploidy in lens epithelial
cells (20) and hexachlorocyclohexane induces poly-
ploidy in meristema root cells (21). High doses of
griseofulvin and colchicine can induce polyploidy in
several systems.
In vitro polyploidization is seen after treatment
of a cell line with PUVA (22), a treatment now sus-
pected to enhance skin carcinogenesis (23). Hamster
cells exposed to asbestos fibers (24) and cell lines
treated with different metals also cause such
changes.
Many of these investigations are fragmentary
and should be reexamined with improved methods
like FCM. But there is obviously an association be-
tween carcinogens or cocarcinogens and polyploidi-
zation. It has not been shown whether the polyploid-
ization effect of these substances is crucial to carci-
nogenesis, or whether it is merely an epiphenome-
non. Cowell and Wigley (25) found evidence of poly-
ploidization early in the carcinogenic process, and
identified tetraploid cells in early stages of subman-
dibulary gland carcinogenesis as probable precur-
sors of malignant near-tetraploid tumor stemlines.
When large numbers of malignant tumors are ex-
amined, the DNA content of stemlines is found to
be mostly tetraploid or near-tetraploid and diploid
or near-diploid (26).
This fact also indicates that polyploidization may
take place, probably early in the process.
There are several possible mechanisms behind
polyploidization. Colchicinlike substances may dis-
rupt the spindle apparatus, and other agents may
interfere by causing changes in the SH levels of the
cells. This is probably the mechanism by which
some metals like Hg and Cd disturb the mitotic pro-
cess. The extensive redox changes made by many
carcinogens may likewise be linked to such disturb-
ances of SH level and may thereby affect the mi-
totic spindle, which is dependent on a certain level
of SH groups for proper functioning. The PUVA-in-
duced polyploidization is probably caused by DNA
crosslinks (27). An increased functional load on the
liver caused by hepatotropic agents is often accom-
panied by polyploidization. This may involve physio-
logical mechanisms like adaptation to changed func-
tion or response to growth stimuli and may conse-
quently be reversible.
FCM of Rat Hepatocytes during Early
Stages of AAF Carcinogenesis
Throughout the observation period the ploidy of
hepatocytes from animals on a control diet showed
the normal distribution of diploid, tetraploid and oc-
toploid DNA values. The lack of S-phase pulses and
the low level of thymidine incorporation in short-
term cultures of these hepatocytes is in accordance
with the known low proliferative activity of the
adult liver. The hepatocytes from rats fed AAF
showed the same low proliferative activity mea-
sured by thymidine incorporation and judged from
the microscopic appearance of the liver. In the FCM
histograms, however, progressive changes were
seen from week 12 of AAF feeding. These changes
could be described as an increasing proportion of
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pulses in the hypodiploid and hypotetraploid areas.
At 16 weeks these nuclei with decreased fluores-
cence made up more than 50% of the nuclei (Fig. 3).
Parallel samples stained with either ethidium bro-
mide or mithramycin gave almost identical results.
Provided there was a stochiometric binding of the
fluorochromes to DNA under these conditions,
these changes in the FCM histograms can be inter-
preted as the occurrence of aneuploid nuclei in in-
creasing numbers in the liver during this state of
the carcinogenic process. It is known that drugs can
alter the binding of such dyes to DNA, and although
this possibility cannot be completely excluded, most
evidence supports the view that the changes in flu-
orescence represent a change in DNA content (28).
The progressive nature of these changes, starting
at about the 10th week and comprising about 50%
of the nuclei at the 16th week of exposure to AAF,
fits well with the theory of a disturbed mitotic
process. The average index of thymidine-labeled
cells during this period was 0.15%, which implied
that the cells proliferated at a rate of about 1% per
day. Lesions due to nondisjunction or chromosome
breaks during mitosis would thus accumulate at
about the observed magnitude. Other investigators
have put forward evidence for major alterations in
the genotype of hepatocytes during the pretumor
stage of hepatocarcinogenesis. Stich (29) found
aneuploid DNA content of metaphases in the liver
of rats exposed to dimethylaminoazobenzene.
Barbason et al. (30) and Tates et al. (31) observed
micronuclei in liver cells during an early phase of
DMN-carcinogenesis.
This diversity of genotypes may be the cause of
the well known diversity of phenotypes during
early stages of hepatocarcinogenesis. Major DNA
changes (32) may also play a role in hepatocarcino-
genesis.
The kind of approach used here may be a useful
model, and possibly a test system, for the detection
of substances causing nondisjunction (turbagens) or
chromosome breaks (clastogens). One can thus take
advantage of the metabolic capacity of the rodent
liver for activation of potential carcinogens and
other harmful substances, and combine it with the
use of FCM as a quick and relatively simple and re-
liable method.
FCM of Carcinogen-Induced Proliferative
Lesions of the Liver
Thirty-one proliferative lesions in mice treated
with DMN (see Methods) were classified as prolifer-
ative nodules, adenomas and hepatocellular carcino-
mas. The FCM histograms revealed characteristic
patterns of ploidy and growth in the tumor stem-
lines. The nodules of hyperplasia showed a diploid
and a tetraploid stemline, and the adenomas and
most of the hepatocellular carcinomas were diploid
(Fig. 4). Only two of the 14 hepatocellular carcino-
mas showed signs of aneuploid growth. The 15 rat
liver tumors from AAF-barbiturate-exposed animals
so far examined were all diploid.
Thus most of the liver tumors analyzed showed a
low (2c) ploidy despite the enhanced polyploidization
(in the mouse) and aneuploidy (in the rat) found in
the pretumor stages. A clonal diploid growth of
early liver tumors in mouse (33) and rat (34) has
been found by microspectrofluorometry and chrom-
osome counting, and has been interpreted as a sign
of the fetal character of the liver tumors. Because
most of the liver tumors in these experiments were
isolated at an early stage of their progress, before
any metastases were found, the material was prob
ably not representative of the entire process. Some
authors (33) have suggested that liver tumors pro-
gress from early differentiated diploid tumors to
undifferentiated carcinomas containing aneuploid
stemlines. The material presented here contained
Clonal growth
tumors
.*neu.io
mouse liver tumor mouse lung tumor
FIGURE 4. Clonal growth in a liver containing aneuploid
and/or polyploid hepatocytes (top). The histograms of a
hepatocellular carcinoma with a diploid stemline and a
dominating S phase (left) (4) and a mouse lung tumor with
an aneuploid stemline (right) (26) are shown.
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only few undifferentiated carcinomas, but among
these aneuploidy was found by the FCM measure-
ments.
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